Search Results

There are 677 results for: content related to: Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null responders

  1. You have free access to this content
    Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection

    Hepatology Research

    Volume 44, Issue 14, December 2014, Pages: E360–E367, Mika Miura, Shinya Maekawa, Mitsuaki Sato, Nobutoshi Komatsu, Akihisa Tatsumi, Shinichi Takano, Fumitake Amemiya, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto and Nobuyuki Enomoto

    Version of Record online : 10 APR 2014, DOI: 10.1111/hepr.12316

  2. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  3. You have free access to this content
    Review article: the efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 3, August 2015, Pages: 258–272, C. Bunchorntavakul and K. R. Reddy

    Version of Record online : 27 MAY 2015, DOI: 10.1111/apt.13264

  4. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2

    Hepatology Research

    Volume 46, Issue 2, February 2016, Pages: 129–165, Yasuhiro Asahina, Namiki Izumi, Kumada Hiromitsu, Masayuki Kurosaki, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu and Hiroshi Yotsuyanagi

    Version of Record online : 15 FEB 2016, DOI: 10.1111/hepr.12645

  5. Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy

    Journal of Medical Virology

    Volume 87, Issue 11, November 2015, Pages: 1913–1920, Satoshi Yoshimi, Michio Imamura, Eisuke Murakami, Nobuhiko Hiraga, Masataka Tsuge, Yoshiiku Kawakami, Hiroshi Aikata, Hiromi Abe, C. Nelson Hayes, Tamito Sasaki, Hidenori Ochi and Kazuaki Chayama

    Version of Record online : 16 JUN 2015, DOI: 10.1002/jmv.24255

  6. You have free access to this content
    Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir

    Hepatology

    Volume 58, Issue 3, September 2013, Pages: 902–911, Fiona McPhee, Dennis Hernandez, Fei Yu, Joseph Ueland, Aaron Monikowski, Arlene Carifa, Paul Falk, Chunfu Wang, Robert Fridell, Timothy Eley, Nannan Zhou and David Gardiner

    Version of Record online : 16 JUL 2013, DOI: 10.1002/hep.26388

  7. Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report

    Hepatology Research

    Volume 46, Issue 7, June 2016, Pages: 707–712, Tomokazu Kawaoka, Michio Imamura, Kei Morio, Yuki Nakamura, Masataka Tsuge, C. Nelson Hayes, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, Kouhei Ishiyama, Kentaro Ide, Hirotaka Tashiro, Hideki Ohdan and Kazuaki Chayama

    Version of Record online : 2 NOV 2015, DOI: 10.1111/hepr.12602

  8. You have free access to this content
    Poster Sessions

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 93A–207A,

    Version of Record online : 1 OCT 2015, DOI: 10.1002/hep.28162

  9. Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism

    Hepatology Research

    Yoshihito Uchida, Jun-ichi Kouyama, Kayoko Naiki, Kayoko Sugawara, Mie Inao, Yukinori Imai, Nobuaki Nakayama and Satoshi Mochida

    Version of Record online : 30 MAR 2016, DOI: 10.1111/hepr.12673

  10. You have free access to this content
    Integrating daclatasvir into hepatitis c therapy

    Clinical Liver Disease

    Volume 7, Issue 1, January 2016, Pages: 1–4, Omobonike Oloruntoba and Andrew J. Muir

    Version of Record online : 29 JAN 2016, DOI: 10.1002/cld.524

  11. Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

    Hepatology Research

    Eiichi Ogawa, Norihiro Furusyo, Naoki Yamashita, Akira Kawano, Kazuhiro Takahashi, Kazufumi Dohmen, Makoto Nakamuta, Takeaki Satoh, Hideyuki Nomura, Koichi Azuma, Toshimasa Koyanagi, Kazuhiro Kotoh, Shinji Shimoda, Eiji Kajiwara, Jun Hayashi and The Kyushu University Liver Disease Study(KULDS) Group

    Version of Record online : 10 JUN 2016, DOI: 10.1111/hepr.12738

  12. Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis

    Therapeutic Apheresis and Dialysis

    Ryoichi Miyazaki and Kyoko Miyagi

    Version of Record online : 21 APR 2016, DOI: 10.1111/1744-9987.12407

  13. You have full text access to this OnlineOpen article
    A phase 3, open-label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin

    Journal of Gastroenterology and Hepatology

    Accepted manuscript online: 22 MAR 2016, Lai Wei, Mingxiang Zhang, Min Xu, Wan-Long Chuang, Wei Lu, Wen Xie, Zhansheng Jia, Guozhong Gong, Yueqi Li, Si Hyun Bae, Yong-Feng Yang, Qing Xie, Shumei Lin, Xinyue Chen, Junqi Niu, Jidong Jia, Tushar Garimella, Anne Torbeyns, Fiona McPhee, Michelle Treitel, Philip D Yin and Ling Mo

    DOI: 10.1111/jgh.13379

  14. Current prospects for interferon-free treatment of hepatitis C in 2012

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 38–45, Catherine AM Stedman

    Version of Record online : 19 DEC 2012, DOI: 10.1111/jgh.12028

  15. Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older

    Journal of Medical Virology

    Norio Akuta, Hitomi Sezaki, Fumitaka Suzuki, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 8 JUN 2016, DOI: 10.1002/jmv.24592

  16. Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace

    Reviews in Medical Virology

    Volume 25, Issue 4, July 2015, Pages: 254–267, Erik De Clercq

    Version of Record online : 4 JUN 2015, DOI: 10.1002/rmv.1842

  17. You have full text access to this OnlineOpen article
    Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients

    Journal of Gastroenterology and Hepatology

    Volume 31, Issue 1, January 2016, Pages: 14–22, Hiromitsu Kumada, Fumitaka Suzuki, Yoshiyuki Suzuki, Joji Toyota, Yoshiyasu Karino, Kazuaki Chayama, Yoshiiku Kawakami, Shigetoshi Fujiyama, Takayoshi Ito, Yoshito Itoh, Etsuko Tamura, Tomoko Ueki, Hiroki Ishikawa, Wenhua Hu, Fiona McPhee, Misti Linaberry and Eric Hughes

    Version of Record online : 30 DEC 2015, DOI: 10.1111/jgh.13073

  18. You have free access to this content
    Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 742–748, Kazuaki Chayama, Shoichi Takahashi, Joji Toyota, Yoshiyasu Karino, Kenji Ikeda, Hiroki Ishikawa, Hideaki Watanabe, Fiona McPhee, Eric Hughes and Hiromitsu Kumada

    Version of Record online : 30 JAN 2012, DOI: 10.1002/hep.24724

  19. You have free access to this content
    Speaker Abstracts

    Journal of Viral Hepatitis

    Volume 22, Issue S3, September 2015, Pages: 1–18,

    Version of Record online : 9 SEP 2015, DOI: 10.1111/jvh.12440

  20. You have free access to this content
    Treatment of hepatitis C virus genotype 3-infection

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 18–23, Stanislas Pol, Anaïs Vallet-Pichard and Marion Corouge

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12405